Does the upstaging of breast cancer based on grade and hormone receptor status in AJCC 8 change your treatment recommendations?
Community PollStarted
How would you recommend treating a healthy >50 yo with high grade, triple negative, T2, treated with BCS and adjuvant chemotherapy?
103 physicians have voted
Join Mednetto vote and see how they answered.
1 Answer
Mednet MemberInvited Expert
Radiation Oncology · New York University School of Medicine
Answered on
The new stage should not in and of itself change management as the data and studies remain unchanged. Thus, for triple negative cancers, I would continue to hypofractionate if intending to treat the breast alone. In cases where I would consider RNI based on the available data (MA20 and EORTC 22922),...
Join for free or sign in to see the full answer